INTRODUCTION
Skin morphogenesis is a complex process requiring the spatial and temporal orchestration of distinct molecular signaling pathways to ensure correct development of epidermal lineages such as interfollicular epidermis (IFE), hair follicles (HF), and sebaceous glands. Initiation of HF development is mainly conducted by b-catenin and SHH signaling (Huelsken et al., 2001; Blanpain and Fuchs, 2009; Hsu et al., 2014) , resulting in formation of hair placodes between embryonic day (E)15 and E17 (Tumbar, 2012) . After the critical step of placode formation, SHH stimulates proliferation of cells within this structure, which then grow down into the dermis as hair germs and further develop into hair pegs between E17 and E18 (Hsu et al., 2014) . Continuous growth of the hair peg leads to the formation of a mature HF, which is constituted of highly proliferative progenitor cells, the so-called matrix, at the bottom. Progeny of the matrix gives rise to the distinct differentiated epithelial cell layers, which comprise the hair or function in hair guidance (Hsu et al., 2014; Adam et al., 2018) . The cell layers from the outer to innermost layer are outer root sheath (ORS), companion layer, three layers of inner root sheath (IRS), cuticle, cortex, and medulla. WNT/b-catenin and bone morphogenetic protein (BMP) signaling were shown to orchestrate hair layer differentiation by temporal layering of signaling effectors (Adam et al., 2018) . Impairment in the formation of solely one layer is sufficient to induce the collapse of the hair shaft and sustained disruption of hair development (DasGupta and Fuchs, 1999; Kaufman, 2003) .
Besides instructive Wnt/b-catenin and BMP signaling pathways, epidermal growth factor receptor (EGFR) signaling strongly contributes to skin development and homeostasis of mice and humans. Mice completely lacking EGFR are born with open eyes and display severe skin defects, including a pronounced delay in HF development (Miettinen et al., 1995; Sibilia and Wagner, 1995; Threadgill et al., 1995) . Expression of a dominant-negative mutant of EGFR in keratinocytes (Murillas et al., 1995) and hair transplantation experiments (Hansen et al., 1997) revealed that EGFR-deficient HFs are able to progress through morphogenesis for about 2 weeks after birth, but then fail to enter catagen. Similarly, humanized EGFR mice (hEGFR KI/KI ) exhibit impaired HF morphogenesis, alterations in morphology and distribution of HFs, and a failure in anagen to catagen transition owing to inefficient expression of the hEGFR in the skin (Sibilia et al., 2003) . At postnatal day (P)90, hEGFR KI/KI mice mostly contained degenerated HFs with thin hair cell layers, which were partly destroyed. Later, studies in conditional knockout mice lacking the EGFR specifically in the epidermal lineage (Nagao et al., 2012; Lichtenberger et al., 2013; Mascia et al., 2013; Bichsel et al., 2016) confirmed that loss of EGFR in keratinocytes is sufficient to induce skin differentiation defects, catagen block, loss of the HF niche, and baldness. Moreover, epidermis-specific EGFR knockout results in severe skin inflammation and confers high susceptibility to S. aureus infections. Similar phenotypes have also been observed in cancer patients receiving anti-EGFR therapies (Lichtenberger et al., 2013; Mascia et al., 2013) . In contrast, mice harboring either the naturally occurring EGFR mutation waved2 (Luetteke et al., 1994) or the transforming growth factor (TGF)-a mutation waved1 (Crew, 1933; Luetteke et al., 1993) only show a mild phenotype characterized by wavy hair coat and whiskers but otherwise normal physiology. TGFa shows specific expression in cells of the IRS (Luetteke et al., 1993) , suggesting an important role of EGFR signaling in the control of epithelial hair layer development and hair shape, whereas EREG and AREG have been shown to affect sebocyte numbers or sebaceous gland size (Dahlhoff et al., 2014; Li et al., 2016) .
So far it has been poorly investigated how much the skin inflammation developing in the absence of epidermal EGFR affects the stem cell compartments thus aggravating the resulting phenotypes. Therefore in this study we employed conditional mouse models allowing us to dissect the cell-autonomous functions of EGFR signaling in distinct keratinocyte and stem cell compartments independently of the non-cellautonomous contribution of inflammation. Our results indicate that EGFR signaling ensures DNA integrity in proliferative compartments, where accumulation of DNA damage results in TP53-dependent cell death. Moreover, we demonstrate that EGFR controls transcription factor expression in the innermost epithelial hair lineages, which is required for hair shaft differentiation.
RESULTS
Previous studies have shown that skin-specific genetic ablation of EGFR during murine embryonic development causes profound defects of HF morphogenesis, but so far lacked detailed mechanistic analysis. Developing HFs need to go through several sequential phases to give rise to a mature HF ( Figure 1A ). To specifically investigate the function of EGFR signaling during the specification and growth phase of HF morphogenesis, Egfr fl/fl mice were crossed with K5Cre transgenic mice to generate mice lacking the EGFR already during embryonic development in the epidermal lineage (Egfr Dep mice, Figures S1A and S1B; Table S3 ; Lichtenberger et al., 2013) . Time course analysis during the growth, catagen, and telogen phases of HFs showed that Egfr Dep mice present a significant delay in HF growth , a catagen block ( Figures 1C and 1D ), and hair shape alterations ( Figure S1C ).
EGFR Deficiency Does Not Result in Alterations of HF Specification during Morphogenesis
First, we analyzed HF specification at late embryonic time points to investigate whether lack of EGFR may impair early HF development. Staining for E-Cadherin confirmed correct anterior-to-posterior orientation of hair pegs as detected by the absence of E-Cadherin expression at the anterior part of the HF (Muller-Rover et al., 1999; Devenport and Fuchs, 2008) in both control and Egfr Dep mice ( Figure 1E ). Furthermore, the angle between IFE and HF was mainly similar between control and Egfr Dep mice (Figures 1F and 1G) . Despite HF growth differences, we did not find differences in expression of hair follicle stem cell (HFSC) fate factors in newborn mice: histological stainings for the HF progenitor/stem cell markers P-Cadherin and LHX2 (Folgueras et al., 2013) ( Figure 1H ) and the NFATc1-positive or Nephronectin (NPTN)-positive prospective bulge region in HF (Horsley et al., 2008; Fujiwara et al., 2011) (Figures 1I and 1J) showed robust expression and correct location of those factors in embryonic and newborn skin of Egfr Dep mice. These results demonstrate that EGFR is not required to induce embryonic HFSC specification but exerts its function on proper HF morphogenesis during the growth phase.
EGFR Controls Genes Required for Epidermal Differentiation and DNA Integrity
To uncover the genes involved in EGFR-mediated regulation of the growth of epidermal lineages, RNA sequencing (RNA-seq) analysis was performed on sorted IFE and ORS cells from postnatal day (P)2 mice. To label ORS cells we crossed Egfr Dep with LGR5Cre ERT2 GFP mice to make use of LGR5-driven GFP expression as an ORS marker (Jaks et al., 2008) , whereas IFE cells were defined as SCA-I hi ITGA6 hi cells ( Figures S2A-S2C ). The time point P2 was chosen, because at that stage there was still no immune cell infiltration in the skin of Egfr Dep pups ( Figure S2D ), but a delay in HF growth was already detectable ( Figure 1B) . We observed reduced GFP expression in ORS cells of Egfr Dep mice at P2, although the total fraction of LGR5-expressing cells was similar to control mice ( Figures S2E-S2H ). RNA-seq analysis showed strong expression of Egfr, Erbb2, and Erbb3 in IFE and ORS of control mice, whereas there was no expression of Erbb4. Furthermore, we observed no or only low EGFR ligand expression in the different epidermal compartments, like low Epgn expression in the IFE, and low Hb-egf in both IFE and ORS ( Figure S2I ).
Analysis of differentially expressed genes between control and Egfr Dep mice revealed that loss of EGFR significantly affects the expression of structural genes (Spink5, Lce1e1, Flg, Sprr1a, Klk7, Gjb4), as well as of genes regulating cell cycle and apoptosis (Perp, Cep120, Klhdc5, Egr1, Fos) in IFE or ORS cells (Figures  2A-2D; Table S1A) . Figure S2 and Tables S1A-S1F.
EGFR Controls Alternative Splicing, which Regulates Centrosome Function and DNA Integrity
As the list of differentially expressed genes included a variety of targets that were either already shown to be directly linked to EGFR signaling, such as Flg (Franzke et al., 2012) , or belonged to an expected biological process, namely, epidermal development, we focused on novel targets not yet reported to regulate epidermal integrity in the context of EGFR signaling. One of those target genes was Srsf2 ( Figure 2B ). The product of this gene is required for the formation of the earliest ATP-dependent splicing complex and contributes to constitutive as well as alternative splicing (Graveley and Maniatis, 1998) . To functionally investigate whether lack of EGFR might affect mRNA splicing, we analyzed our RNA-seq datasets for alternative exon usage employing JunctionSeq . For both compartments, IFE and ORS, we detected a high number of alternative transcripts upon comparison of control and EGFR-deficient keratinocytes. Importantly, these genes group into distinct GO terms like ''intracellular signal transduction,'' ''Wnt pathway,'' ''cell cycle,'' or ''organelle part'' ( Figures 2E and 2F , Table S1B ).
To gain more specific information from the large amount of alternatively used exons and junction sites, we focused on the 191 (11.5%) affected overlapping genes between IFE and ORS ( Figure 2G , Table S1C ). GO term analysis on those overlapping targets elucidated that EGFR is required to control the ''perinuclear region of cytoplasm,'' ''cell cycle,'' and ''death'' in both IFE and ORS ( Figure 2H , Table S1D ). Deeper investigation of the genes belonging to the term ''cell cycle'' revealed a high number of genes important in centrosome function and DNA damage repair, e.g., Cntrl, Cep192, Clspn, and Bub1b (Table S1E) , and an almost equal number of differentially used exons and junction sites ( Figure 2I , Table S1F ).
EGFR Regulates Proliferation and Prevents DNA Damage in Epidermal Lineages
As both global gene expression and alternative splicing analysis identified genes involved in cell cycle, centrosome function, and DNA damage response we hypothesized that a strong disbalance of cell turnover or survival and apoptosis could explain the growth delay of EGFR-deficient HFs. In light of previous reports on an important function of EGFR in promotion of proliferation (Hansen et al., 1997; Bol et al., 1998; Xie et al., 1999; Kiguchi et al., 2000; Lichtenberger et al., 2010) , we functionally tested whether EGFR is required for regulating the proliferation rate of distinct keratinocyte populations. RNA-seq analysis showed downregulation of early growth response 1 (Egr1) in the ORS of Egfr Dep mice ( Figure 2B ). It was previously demonstrated that Egr1 is a downstream target of ERK signaling and involved in cell growth and proliferation (Mayer et al., 2009; Tarcic et al., 2011) . We confirmed EGR1 protein absence in the ORS ( Figure 3A ), as well as strongly reduced phospho-ERK1/2 selectively in ORS cells of EGFR-deficient skin ( Figure 3B ). In addition, bromodeoxyuridine (BrdU) pulse-chase experiments showed reduced BrdU incorporation into EGFR-deficient ORS cells after 24h ( Figures 3C and S3A ), providing evidence that EGFR signaling in the ORS is required to induce the ERK signaling cascade, leading to Egr1 induction and cell growth or proliferation. To address whether absence of EGFR also affects proliferation in the IFE, back skin sections from various time points (P5, P8, P10) were stained for Ki67 and additionally analyzed by flow cytometry after a 4h BrdU pulse. Our results show that both numbers of Ki67 + cells and BrdU + cells are reduced in IFE of Egfr Dep mice when compared with control mice (Figures 3D, 3E , and S3B). These data confirm previous findings (Bol et al., 1998; Xie et al., 1999; Kiguchi et al., 2000; Lichtenberger et al., 2010) and provide more detailed insights into the important role of EGFR in promoting proliferation of the epidermal lineage.
Detailed depiction of exon usage of Centriolin (Cntrl) ( Figure S3C ) shows that EGFR-deficient keratinocytes preferentially skip exons 11, 15, and 16. Exon 11 encodes an alternative 3 0 UTR and leads to a shorter transcript, which is known as a 110-kDa variant of Cntrl termed Cep110. Skipping of the alternative part of exon 11 leads to an increase in full-length transcript, encoding a 270-kDa variant of Cntrl, including a domain required for centrosome localization (Szebenyi et al., 2007) . Exons 15 and 16 contribute to the stathmin domain of CNTRL, which is involved in regulation of mitotic spindle assembly. Further investigation of Claspin (Clspn) mRNA shows that Egfr Dep mice skip exon 12 ( Figure S3D ). Claspin is required for cell-cycle arrest in response to DNA damage via activation of CHK1 (Lee et al., 2003) . Interestingly, exon 12 encodes a protein region involved in forming the CHK1-activating domain (CKAD), suggesting that exon skipping leads to reduced binding of CLSPN to CHK1 and subsequently to reduced clearance of DNA damage.
To test this hypothesis, we investigated centrosome numbers, DNA damage, and apoptosis. Pericentrin stainings of primary keratinocytes revealed an increased fraction of EGFR-deficient keratinocytes displaying more than two centrosomes ( Figures 3F and 3G) . Moreover, we observed nuclear fragmentation in keratinocytes lacking EGFR ( Figure 3H ). As both, WT and Egfr Dep keratinocyte cultures, were negative for the differentiation marker K1, we exclude that fragmentation of nuclei might be due to accelerated differentiation of EGFR-deficient keratinocytes ( Figure S3E ). To analyze whether loss of DNA integrity is accompanied by increased cell death, we stained back skin sections for active caspase 3. Apoptotic cells were detected in the IFE and hair pegs of E18.5 epidermis ( Figure 3I ) as well as in P10 IFE and matrix of Egfr Dep mice ( Figure 3J ). Furthermore, staining for the DNA damage marker gH2AX uncovered a high number of gH2AX foci in skin of Egfr Dep mice, but not in control mice ( Figure 3K ). The presence of DNA damage was accompanied by stabilization and accumulation of TP53 in nuclei of matrix cells from Egfr Dep mice ( Figure 3L ). These data demonstrate that absence of EGFR leads to accumulation of DNA damage, which subsequently induces TP53 stabilization and apoptosis. -4D ), suggesting a TP53-dependent mechanism for cell death in these highly proliferative epidermal compartments. Upon closer investigation of other epithelial compartments in the epidermal lineage, we also detected apoptotic cells in the hair shaft of Egfr Dep mice, which were, however, not affected by additional TP53 deletion (Figures 4E and 4F) , providing evidence for a TP53-independent apoptotic mechanism in postmitotic cells. We could also confirm the presence of apoptosis in innermost hair layers, such as medulla cells, by transmission electron microscopy ( Figure 4G ). To characterize whether apoptosis in the hair shaft affects the differentiation of epithelial hair layers in mice lacking epidermal EGFR, we stained for hair-layer-specific keratins in control, Egfr Dep mice, and Egfr/p53 Dep mice. Both Egfr Dep mice and Egfr/p53 Dep mice exhibited onset of hair layer differentiation, but displayed an early loss of those layers ( Figure 4H ). These data indicate TP53-dependent cell death in proliferative keratinocytes as well as a TP53-independent mechanism of apoptosis in the non-proliferative, differentiated cells of the hair shaft upon lack of EGFR signaling.
EGFR Controls Hair Lineage Transcription Factor Expression
To investigate whether transcription factors involved in hair layer differentiation showed altered expression upon EGFR deletion, we stained for IRS-specific transcription factor GATA-3, as well as for IRS-and HSspecific factor LEF1 (Merrill, 2001; Kaufman, 2003; Adam et al., 2018) . GATA-3 expression was not different between control and Egfr Dep mice ( Figure 5A ). However, LEF1 was only found to be expressed in IRS cells of Egfr Dep mice, but not in hair shaft cells ( Figure 5B ). Staining for trichohyalin AE15, which is present in differentiated IRS and medulla, revealed lack of properly differentiated medulla cells in Egfr Dep mice ( Figure 5C ).
Based on our results, we propose that EGFR signaling affects spatial layering during HF growth and differentiation ( Figures 5D and 5E ). First, EGFR promotes cell proliferation and ensures DNA integrity in highly proliferative epidermal compartments, such as IFE, ORS, and matrix. Upon loss of EGFR in those compartments, accumulation of DNA damage mediates TP53-dependent apoptosis ( Figure 5D ). Second, EGFR controls hair-layer-specific transcription factor expression to regulate epithelial hair layer specification and differentiation. EGFR deficiency leads to absence of proper differentiation cues for hair shaft cells, resulting in TP53-independent loss of the medulla layer ( Figure 5E ). 
Loss of EGFR in Adult HFSCs Results in Growth Delay
We next investigated whether EGFR also serves a growth-promoting function in adult HFSCs. Therefore, we first tested whether EGFR is expressed in adult HFSCs by applying fluorescently labeled epidermal growth factor to cell suspensions of adult (P45) wild-type mice after completion of the first hair cycle, when hair is in early telogen. We detected high EGFR expression in CD34 + old and new bulge stem cells, intermediate expression in IFE, and no expression in CD45 + hematopoietic cells using flow cytometric analysis ( Figure S5A) . These results were confirmed by EGFR stainings on back skin sections ( Figure S5B ). Furthermore, EGFR expression was detected within the matrix, the ORS and the IRS of anagen HFs (Figures S5C and S5D ). During catagen, scattered EGFR expression was observed in the retracting HF (Figure S5E) . These results suggest that EGFR signaling is required in adult HFSCs. Because it is not possible to investigate activation and growth of adult HFSCs in Egfr Dep mice owing to HF degradation and progressive hair loss (Lichtenberger et al., 2013) , we crossed Egfr fl/fl to Lgr5Cre ERT2 GFP mice to delete the EGFR after completion of the first postnatal hair cycle (from P43-P47) in lower bulge and secondary hair germ (2 HG) HFSCs by tamoxifen injection (EGFR DLGR5ÀERT2 mice, Figure S5F ). Egfr DLGR5-ERT2 mice were monitored during progression of the second postnatal hair cycle until P88. EGFR deletion was confirmed by genomic DNA ( Figure S5G ) and by immunohistochemistry (IHC) analysis ( Figure S5H ). Egfr DLGR5-ERT2 mice exhibited delayed entry into the second hair cycle ( Figure 6A ), demonstrating that EGFR signaling is involved in HFSC activation and proliferation. This was further underlined by the finding that by the time of analysis most follicles of control mice had completed the second hair cycle and already returned to telogen, whereas the majority of HFs of Egfr DLGR5-ERT2 mice was still in anagen of the second cycle (Figure 6B) . Importantly, Egfr DLGR5-ERT2 mice did not display an immune cell infiltrate ( Figure 6C ), emphasizing that the growth delay observed in Egfr DLGR5-ERT2 mice is solely due to cell-autonomous defects in HFSCs.
To identify molecules deregulated in adult HFSCs upon loss of EGFR, we performed flow cytometric cell sorting of LGR5 + cells from P88 control and Egfr DLGR5-ERT2 mice and subjected them to RNA-seq ( Figures  S5I and S5J) . We found 145 genes to be significantly differentially expressed between LGR5 + cells derived from control and Egfr DLGR5-ERT2 mice ( Figures 6D and 6E , Table S2A ). Among the differentially expressed genes, we found genes encoding for structural proteins that were deregulated in our dataset obtained from P2 Egfr Dep mice such as Gjb4 and Klk7 and also genes encoding for signaling and growth molecules such as Wnt3a or Bmp7 indicating that lack of EGFR signaling in LGR5 + HFSCs broadly shifts the balance of molecules regulating HFSC behavior. Overall, affected genes show enrichment for GO terms such as ''cellular response to chemical stimulus,'' ''tissue development,'' ''molting cycle,'' or ''growth'' ( Figures  6F and 6G , Tables S2B and S2C ). Thus loss of EGFR negatively alters the susceptibility of HFSCs to respond to activating cues ( Figure 6H ).
Investigation of receptor and ligand expression in control
LGR5 + HFSCs revealed that similar to P2 IFE and ORS, these cells highly express Egfr, Erbb2, and Erbb3, but not Erbb4. Moreover, LGR5 + HFSCs display low expression of the ligands Tgfa, Epgn, and Hb-egf, whereas all other ligands are not expressed ( Figure S5K ).
Furthermore, exons or junction sites of more than 300 genes were affected by alternative splicing alterations in LGR5 + cells of Lgr5 + Egfr DLGR5-ERT2 mice, enriching for GO terms associated with cell stimulation and intracellular metabolic processes ( Figure S5L , Table S2D ). Notably, we detected a substantial overlap of alternative transcripts from 213 genes (10.3%) between P2 IFE + ORS and P88 LGR5 + cells ( Figure S5M , Table S2E ), leading to the assumption that EGFR has some identical targets in distinct epidermal compartments at different time points, as well as a variety of specific targets depending on epidermal cell identity and age. Shared target genes display significant enrichment for GO terms such as ''organelle,'' ''intracellular signal transduction,'' and ''cell cycle'' ( Figure S5N , Table S2F ), further underlining that EGFR is required for proliferation and proper orchestration of molecules and pathways involved in both HF development and adult HFSC activation and new HF growth. Figure S4 .
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DISCUSSION
Our study demonstrates that the phenotype of EGFR-deficient skin is multifactorial, displaying alterations in expression of structural proteins, DNA integrity and DNA damage, proliferation, and apoptosis, but not stem cell identity genes. Lack of EGFR in newborn skin reduces proliferation in ORS and also in IFE keratinocytes. Analysis of RNA-seq data and subsequent histological analysis demonstrate reduced ERK activation and loss of expression of the ERK downstream target Egr1 (Mayer et al., 2009; Tarcic et al., 2011) in EGFR-deficient ORS. In various studies on cancer cells and in mouse models of ERBB2 overexpression a prominent function of EGFR signaling in promoting keratinocyte proliferation via ERK phosphorylation has been shown (Lichtenberger et al., 2010) (Bol et al., 1998; Xie et al., 1999; Kiguchi et al., 2000) . The proliferation-promoting function of EGFR was mainly assessed in a hyperproliferative context of tumor cells, whereas only little information is available in the framework of epidermal morphogenesis and homeostasis. Albeit a reduction of proliferating keratinocytes was shown for the IFE of Egfr À/À mice (Hansen et al., 1997) , this was never formally shown for the ORS. Importantly, previous studies investigating adult EGFR-deficient mice could not show changes in pERK by using in vitro assays (Nagao et al., 2012) or in vivo analysis . The absence of effects on pERK levels might be due to assessment of fully developed adult murine skin, and not neonatal mice, undergoing epidermal morphogenesis. In addition, many other pathways have been shown to induce ERK phosphorylation in keratinocytes. Thus our data provide new insight into a growth-promoting function of EGFR in the developing ORS.
We assessed the specification of committed HFSC populations during early HF development by using markers LHX2, NFATc1, and NPNT. All factors were equally expressed and localized in control and Egfr Dep mice. Among the group of epidermal structural genes displaying differential gene expression in our RNAseq dataset were factors that each alone can result in severe epidermal or hair alterations: mutations in Flg are known to be involved in the development of atopic dermatitis (Tholen et al., 2016) , mutations in Spink5 are reported to cause Netherton syndrome (Raghunath et al., 2004) , and mutations in Gjb4 are associated with erythrokeratodermia variabilis (Richard et al., 2003) . These findings demonstrate that one critical role of EGFR signaling is transcriptional regulation of structural genes directly involved in epidermal differentiation.
We identified centrosome assembly and function as a novel downstream process of EGFR signaling by our expression and alternative splicing analysis. IFE keratinocytes lacking EGFR display centrosome amplifications. Functional consequences of abnormal centrosome numbers due to a disbalance in centrosomal proteins were previously shown to correlate with genome instability (Vitre and Cleveland, 2012; Nam et al., 2015) . Importantly, defects in centrosome or mitotic spindle assembly leading to the generation of multiple nuclei are partially causative for the rare disease trichothiodystrophy (Nakabayashi et al., 2005; Zhang et al., 2007) , which affects DNA repair and hair structure.
Generally, genome instability and nuclear fragmentation are accompanied by DNA damage. In the epidermis, centrosome amplifications result in impaired mitosis and TP53-mediated cell death (Kulukian et al., 2015) . In our datasets, we find transcriptional upregulation of genes associated with cellular response to DNA damage in Egfr Dep mice: TP53 apoptosis effector Perp is known as an apoptosis-associated target of TP53, involved in its stabilization (Attardi et al., 2000; Davies et al., 2011) , and Hmgn2 was reported to facilitate chromatin accessibility for DNA repair machinery (Subramanian et al., 2009) . So far, cross talk between EGFR and TP53 signaling was only shown in vitro (Kryeziu et al., 2013) . Importantly, our data for the first time provide in vivo evidence for a role of EGFR signaling in prevention of DNA damage in proliferating cells and for susceptibility of epidermal cells to TP53-mediated apoptosis upon loss of EGFR. Despite the DNA-damage-induced apoptosis in proliferative keratinocyte compartments, we detect TP53-independent cell loss in differentiated epithelial hair layers comprising the hair shaft. Suprabasal-transit-amplifying cells, which give rise to those innermost hair layers, display a requirement for EGFR signaling to induce correct transcription factor expression of the lineage diversification factor Lef1. During morphogenesis, LEF1 protein is not detectable in hair shaft cells of EGFR-deficient epidermis, thus presumably reducing the expression of hair-shaft-specific genes. These defects ultimately lead to loss of hair shaft cells, hair structure alteration, and hair malformation.
Limitation of the Study
We are formally not able to discriminate between a cell-autonomous function of EGFR in epithelial hair lineage differentiation, or a secondary effect on hair shaft differentiation following absence of EGFR in all epithelial skin lineages. To date, there are no-hair shaft-specific Cre lines available that would allow detailed investigation of the effects of Egfr deletion in these particular hair lineages.
METHODS
All methods can be found in the accompanying Transparent Methods supplemental file. Figure S5 and Tables S2A-S2F.
SUPPLEMENTAL INFORMATION
Supplemental Information can be found online at https://doi.org/10.1016/j.isci.2019.04.018.
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Transparent Methods

Mice
Mice were kept in the animal facilities of the Medical University of Vienna in accordance with institutional policies and federal guidelines. Animal experiments were approved by the Animal Experimental Ethics Committee of the Medical University of Vienna and the Austrian Federal Ministry of Science and Research (animal license numbers: GZ 66.009/124-BrGT/2003; GZ 66.009/109-BrGT/2003; BMWF-66 .009/0073-II/10b/2010; BMWF-66.009/0074-II/10b/2010). EGFR fl/fl mice were kept in C57BL/6 background for more than 30 generations and were crossed with K5Cre transgenic mice (Tarutani et al. 1997) , (LGR5-EGFP-Cre ERT2 knock-in mice (Barker et al. 2007 ) and p53 fl/fl mice (Marino et al. 2000) . While K5Cre and LGR5-EGFP-Cre ERT2 mice were of C57BL/6 background, p53 fl/fl mice were of mixed background. Sequences of genotyping primers can be found in Supplemental  Table S2 . No phenotypic differences have been identified between male and female mice, thus all experiments were conducted using both genders. Age of analysed mice is indicated in each figure legend. Embryonic and newborn pups were sacrificed by decapitation. Mice older than P3 were sacrificed by cervical dislocation. For Tamoxifen-induced deletion of EGFR, 1mg TamoxifenImouse (resolved in 10v/v% EtOH (Roth) and 90v/v% sun flower seed oil (Sigma) was injected for 5 consecutive days from P43-47.
Keratinocyte culture
Back skin was surgically removed and subcutaneous adipose tissue was gently removed. Skin was placed dermal-side down on 0.8% Trypsin (diluted in PBS, Sigma) at 37°C for 30min. Epidermis was peeled off under a sterile laminar flow hood, transferred to a 1.5ml Eppendorf tube containing PBS + 2% chelated FCS and chopped into tiny pieces using sterile scissors. This solution was transferred to 15ml Falcon tube and after adding 5ml DNaseI solution (Sigma, #DN25, 250µg/ml in MEM + 8% chelated FCS) incubated on a rotating shaker at 37°C for 45min. 10ml PBS + 2% chelated FCS were added and the solution was pipetted up and down several times and passed over a 70µm cell strainer into a new tube. After centrifugation at 300g for 10min, cells were resuspended in keratinocyte medium (PromoCell, medium constituted according to the manufacturer's instructions), counted and incubated at a concentration of 5x10 4 cells/well in pre-coated 8-well chamber slides at 32°C (Coating medium: 100ml MEM, 10ml BSA (FractionV 1mg/ml), 1ml 2mM HEPES pH 7.3, 1ml PureCol (Inamed BioMaterials), 1ml 1mg/ml Fibronectin, 1.16ml 100mM CaCl2). 24-36 hours later, medium was changed and cells were allowed to grow for 2-3 more days.
BrdU incorporation assay
For in vivo ORS BrdU incorporation assays, newborn mice were injected with 0.625mg BrdU once and sacrificed 24h later. For IFE BrdU incorporation assays, mice of 5, 8, or 10 days of age were injected with BrdU and sacrificed 4h later.
Histology (Sections)
For histological analysis, skin was processed as described previously (Amberg et al. 2015) . Briefly, paraffin-embedded skin biopsies were cut into 4μm thin sections and stained with Hematoxylin & Eosin or Fontana Masson according to standard protocols or subjected to immunohistochemistry (IHC) stainings. For IHC, samples were deparaffinized and rehydrated, antigen retrieval was performed using the respective antigen retrieval buffer and an aptum Retriever 2100 antigen retrieval machine. Endogenous peroxidase was blocked by incubation in 3% H2O2 in Methanol for 10min, followed by biotin blocking using Endogenous Biotin Blocking Kit (LifeTech) for 20min each and blocking of unspecific antibody binding using PBS supplemented with 1% BSA, 5% Horse Serum and 0.1% Triton X-100 for 1h at room temperature before adding primary antibodies. In case primary antibodies were raised in mouse, blocking was performed using M.O.M. kit (mouse on mouse, Vector Laboratories, FKM-2201). Primary antibodies were incubated in antibody blocking buffer (1% BSA, 5% Horse Serum, 0.1% TritonX-100 in PBS) over night at 4°C. Biotinylated secondary antibodies were diluted 1:500 in antibody blocking buffer and incubated at room temperature for 1h, followed by Streptavidin incubation for 30min. After DAB reaction was performed, sections were counterstained with Gill's Hematoxylin, dehydrated and embedded using Entellan.
For BrdU stainings, 4μm paraffin sections were incubated with 1N HCI at 37°C for 1h, blocked with antibody blocking buffer and stained with anti-BrdU antibody (BD, 1:50) at 4°C over night. Secondary antibody was diluted 1:500 in blocking buffer, and together with Hoechst (1μg/ml) incubated for 1h at room temperature, before mounting with DAKO mounting medium.
